Empowered Funds LLC purchased a new position in shares of Cabot Corporation (NYSE:CBT – Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 34,651 shares of the specialty chemicals company’s stock, valued at approximately $3,147,000. Empowered Funds LLC owned about 0.07% of Cabot at the end of the most recent reporting period.
Other large investors have also bought and sold shares of the company. BlackRock Inc. purchased a new stake in shares of Cabot during the second quarter valued at approximately $633,302,000. Bank of America Corp DE purchased a new position in shares of Cabot in the second quarter worth $150,772,000. Norges Bank purchased a new position in shares of Cabot in the fourth quarter worth $49,662,000. Bank of New York Mellon Corp bought a new stake in Cabot during the 2nd quarter valued at $57,445,000. Finally, AQR Capital Management LLC raised its holdings in Cabot by 123.0% during the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock valued at $65,096,000 after buying an additional 478,702 shares during the last quarter. 93.18% of the stock is owned by hedge funds and other institutional investors.
Cabot Stock Performance
Shares of CBT stock opened at $80.56 on Wednesday. The stock has a fifty day moving average of $87.32 and a 200 day moving average of $81.32. Cabot Corporation has a 52 week low of $58.33 and a 52 week high of $94.53. The firm has a market capitalization of $4.16 billion, a price-to-earnings ratio of 22.69, a PEG ratio of 10.86 and a beta of 0.84. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48.
Cabot Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be paid a dividend of $0.4725 per share. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.3%. Cabot’s payout ratio is presently 53.24%.
Analyst Ratings Changes
A number of equities research analysts have issued reports on the stock. Truist Financial set a $100.00 price target on shares of Cabot in a report on Wednesday, August 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research note on Friday, August 21st. UBS Group dropped their target price on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a report on Wednesday, August 5th. Mizuho raised their target price on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, June 25th. Finally, JPMorgan Chase & Co. raised their target price on Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a research note on Friday, August 7th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Cabot currently has an average rating of “Hold” and a consensus target price of $89.00.
Read Our Latest Report on Cabot
Insider Activity
In related news, CEO Sean D. Keohane sold 134,895 shares of the business’s stock in a transaction dated Friday, August 28th. The shares were sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the transaction, the chief executive officer owned 404,134 shares in the company, valued at $34,351,390. The trade was a 25.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have sold a total of 229,597 shares of company stock worth $19,646,746 in the last 90 days. 3.08% of the stock is owned by insiders.
About Cabot
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Further Reading
- Five stocks we like better than Cabot
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
